The product investigation was completed 15-dec-2022.Device evaluation details: according to pictures provided by the customer, blood was observed inside the pebax; however no external damages were observed on it.No other damages or anomalies were observed on it.The device was returned to biosense webster (bwi) for evaluation.A visual inspection of the returned device was performed following bwi procedures.Visual analysis of the returned sample revealed a cut and reddish material in the pebax.The root cause of the damage on pebax cannot be related to the manufacturing process since there is evidence that the device was manufactured in accordance with documented specifications and procedures, it could be related to the handling of the device during the procedure, however, this cannot be conclusively determined.The issue reported by the customer was confirmed a manufacturing record evaluation was performed for the finished device 30779191l number, and no internal action was found during the review.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|